App-Quantinova.ai

Hypercalcaemia in pregnancy due to parathyroid adenoma – would you recognise it?

Asma Bitar - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Primary hyperparathyroidism

Ergocalciferol

Kisspeptin-54 accurately identifies hypothalamic dysfunction in men with congenital hypogonadotropic hypogonadism

Ali Abbara - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypogonadotropic hypogonadism

N/A

Early menopause is associated with increased risk of arterial hypertension: A systematic review and meta-analysis

Panagiotis Anagnostis - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Temporal trends in craniopharyngioma management and long term endocrine outcomes

Ziad HUSSEIN - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Craniopharyngioma

N/A

Raised Metanephrines in SDHB mutation- the hunt for the source

Sing Yang Sim - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pheochromocytoma

Octreotide

Identification of clinical parameters predictive of ARMC5 mutation in a large cohort of primary bilateral macronodular adrenal hyperplasia (PBMAH) patients.

Lucas Bouys - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Reducing short synacthen tests by deriving a novel baseline and 30 min cortisol level for a scottish population

Pauline McAleer - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Tetracosactide

Impact of imputation method on efficacy results from the phase 3 optimal study of oral octreotide capsules in adult patients with acromegaly

Susan Samson - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acromegaly

Oral octreotide

Amiodarone induced thyroid disorders – would you miss them?

Hnin Yu Sanda - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

Simvastatin

Diabetic muscle infarction: A life changing diagnosis with poor long term prognosis

Pramod Manjunath - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Deep vein thrombosis

Aspirin

Physiologically based pharmacokinetic modelling to inform dosing in adrenal insufficiency and congenital adrenal hyperplasia

Martin J Whitaker - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congenital adrenal hyperplasia

Hydrocortisone

Comparability of steroid hormone measurement among 9 European laboratories using liquid chromatography-tandem mass spectrometry (LC-MS/MS): Impact of the blood derivative and of calibration

Flaminia Fanelli - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Heparin

Lateral thinking in new onset diabetes

Htet Htet Aung - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Rheumatoid arthritis

Somatostatin

Splicing machinery is dysregulated in craniopharyngiomas: a novel source of diagnostic, prognostic and therapeutic biomarkers

Antonio C Fuentes-Fayos - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Epithelial tumors

N/A

Disconnection hyperprolactinaemia and its correlation with tumour size: A study of 210 patients with histologically proven non-functioning pituitary macroadenomas

Arpan Das - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pituitary adenomas

N/A

STOPFOP: A european phase II clinical trial using saracatinib to prevent FOP

Bernard Smilde - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Fibrodysplasia ossificans progressiva

saracatinib

VDR-GR complex reduces apoptosis in acute myeloid leukemia cells via reduction of GR transcriptional activity

Angeliki Karapanagioti - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute myelocytic leukemia

Dexamethasone

Demonstration of follicle-stimulating hormone receptor and G protein-coupled estrogen receptor heteromers in vitro via BRET and super-resolution imaging

Clara Lazzaretti - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary alveolar microlithiasis

N/A

A Phase III randomized, controlled trial of a modified-release hydrocortisone formulation in the treatment of classic congenital adrenal hyperplasia

Deborah Merke - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Congenital adrenal hyperplasia

Hydroxyprogesterone caproate

Pancreatic neuroendocrine tumour with suspected extrarenal secretion of 1,25-dihydroxyvitamin D3

Alwyn Yung Zhuang Choo - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypercalcaemia

Zoledronic acid

Filters

45280 Abstracts